Dr. Gint Silins

Position:Principal
Email:gint.silins@spruson.com
Gint Silins

IP Qualifications

Qualification
Registered Australian and New Zealand Patent Attorney
Registered Australian Trade Mark Attorney

Academic Qualifications

Qualification InstitutionYear of Completion
Bachelor of ScienceWollongong University1990
Bachelor of Science (Hons 1)The University of Queensland & CSIRO1991
Doctor of Philosophy (PhD)The University of Queensland & CSIRO1995

Industry Experience

PositionOrganisation/InstitutionDate of Tenure
Research ScientistCSIRO, Division of Tropical Animal Production1991
Research OfficerThe Queensland Institute of Medical Research1995-1998

Fellowships/Memberships/Affiliations

OrganisationLevel
Institute of Patent and Trade Mark Attorneys of Australia (FIPTA)Fellow
Australian Society of Cosmetic Chemists (ASCC)Member
The Australian Institute of Food Science and Technology IncMember

Selected Patent Cooperation Treaty (PCT) Specifications

Publication NumberTitle of Application
WO/2018/068104Leukocyte Adhesive Function Assays, Devices and Uses
WO/2017/201579Arthrogenic Alphavirus Vaccine
WO/2016/176726Diagnostic Methods
WO/2016/023077Biological Markers
WO/2011/140589Plant-based Electrolyte Compositions
WO/2009/111846Mitochondrially Delivered Anti-Cancer Compounds
WO/2008/031171Pro-oxidant Anti-cancer Compounds

Selected Publications - Scientific

Scientific Publications
Clyde-Smith J, Silins G, Gartside M, Grimmond S, Etheridge M, Apolloni A, Hayward N, Hancock JF. Characterization of RasGRP2, a plasma membrane-targeted, dual specificity Ras/Rap exchange factor. J Biol Chem 2000 Oct 13;275(41):32260-7.
Bellomo D, Headrick JP, Silins GU, Paterson CA, Thomas PS, Gartside M, Mould A, Cahill MM, Tonks ID, Grimmond SM, Townson S, Wells C, Little M, Cummings MC, Hayward NK, Kay GF. Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circ Res 2000 Feb 4;86(2):E29-35.
Bergman L, Silins G, Grimmond S, Hummerich H, Stewart C, Little P, Hayward N. A 500-kb sequence-ready cosmid contig and transcript map of the MEN1 region on 11q13. Genomics 1999 Jan 1;55(1):49-56.
Silins G, Grimmond S, Hayward N. Characterisation of a new human and murine member of the DnaJ family of proteins. Biochem Biophys Res Commun 1998 Feb 4;243(1):273-6.
Silins G, Grimmond S, Egerton M, Hayward N. Analysis of the promoter region of the human VEGF-related factor gene. Biochem Biophys Res Commun 1997 Jan 13;230(2):413-8.
Silins GU, Blakeley RL, Riddles PW. Characterisation of genes encoding a nucleoside monophosphate kinase and a L35 ribosomal protein from Babesia bovis. Mol Biochem Parasitol 1996 Feb-Mar;76(1-2):231-44
Experience and Technical Background

Experience in the following areas of patent practice:

  • Patent Drafting
  • Patent Oppositions
  • Local & Foreign Patent Prosecution
  • Patent Searches
  • Validity and Infringement Advice
  • Ownership Challenges
  • Pharmaceutical Extensions of Term
  • Re-examinations
  • Patent Enforcement
  • IP Clauses in Commercial Agreements
  • Due Diligence, Including for IPOs

Primary patent practice areas by technology:

  • Health Care
  • Personal Care
  • Animal Health
  • Food & Beverage
  • Biotechnology
  • Industrial Chemical
  • Clean Energy
  • Agriculture
  • Pharmaceuticals
  • Life Sciences
  • Cosmetics
  • Cosmeceuticals
  • Diagnostics
  • Nutraceuticals
  • Medical Devices
  • Alternative Therapies
  • Applied Chemistry
  • Complementary Medicines

 

 

Research/industry background:

A. General technical areas:

  • Molecular Biology
  • Genetics
  • Bioinformatics
  • Cell Biology
  • Protein Expression
  • Molecular Parasitology
  • Antibody Production
  • Transgenics & Knock-out Mice

B. Honours research:

  •  Molecular parasitology
  •  molecular genetics
  •  protozoan parasites
  •  ticks
  • genome organisation
  • gene structure
  • gene expression
  • gene function
  • protein structure

C. PhD research:

  • Thesis entitled: ‘Molecular Genetics of Babesia bovis. Nuclear
    Genome Organisation and Gene Expression.’ Using molecular
    techniques and bioinformatics to study a protozoan parasite, to
    isolate and characterise its genes/gene expression/genome, and
    to determine its similarities to and differences from the genetics
    of other eukaryotic and prokaryotic organisms.

Would you like to join the Spruson & Ferguson team?


Work For Us

Contact our Expert Team

Contact Us